This is webinar 3 of 3 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this webinar, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. John Magaña Morton to discuss:
- Evaluating patient outcomes measuring weight loss success in terms of reduced disease burden.
- How to adapt treatment plan when interventions are unsuccessful.
- The future of obesity care in gastroenterology.
Register
Learning Objectives
- Discuss the spectrum of therapeutic and surgical options for obesity treatment, including new and emerging strategies.
- Develop personalized obesity treatment plans with patients through shared decision making, encompassing multidisciplinary care.
- Assess disparities in health outcomes for URM patients with obesity.
Faculty
Andres Acosta, MD, PhD, Course Director, Co-host
Assistant Professor of Medicine
Consultant, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Octavia Pickett-Blakely, MD, MHS, Co-host
Associate Professor of Clinical Medicine
Director, GI Nutrition, Celiac Spue and Obesity Program
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania
John Magaña Morton
Medical Director of Bariatric Surgery
Vice Chair of Surgical Quality
Yale School of Medicine and Yale New Haven Health System
New Haven, Connecticut
Pricing
Member
|
Nonmember
|
$Free |
$Free |
Accreditation Statement
The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: June 14, 2023
Disclosures
Andres Acosta
Amgen: Consulting
Gila Therapeutics: Stock Shareholder
Phenomix Sciences: Stock Shareholder
Octavia Pickett-Blakely
Nothing to disclose
John Magaña Morton
Novo: Advisory Committee/ Review Panel
Ethicon: Consulting